173 related articles for article (PubMed ID: 10358028)
21. Vitamin D analogue-specific recruitment of vitamin D receptor coactivators.
Issa LL; Leong GM; Sutherland RL; Eisman JA
J Bone Miner Res; 2002 May; 17(5):879-90. PubMed ID: 12009019
[TBL] [Abstract][Full Text] [Related]
22. Retinoid X receptor is a nonsilent major contributor to vitamin D receptor-mediated transcriptional activation.
Bettoun DJ; Burris TP; Houck KA; Buck DW; Stayrook KR; Khalifa B; Lu J; Chin WW; Nagpal S
Mol Endocrinol; 2003 Nov; 17(11):2320-8. PubMed ID: 12893883
[TBL] [Abstract][Full Text] [Related]
23. Agonist-triggered modulation of the activated and silent state of the vitamin D(3) receptor by interaction with co-repressors and co-activators.
Herdick M; Carlberg C
J Mol Biol; 2000 Dec; 304(5):793-801. PubMed ID: 11124027
[TBL] [Abstract][Full Text] [Related]
24. Vitamin D receptors from patients with resistance to 1,25-dihydroxyvitamin D3: point mutations confer reduced transactivation in response to ligand and impaired interaction with the retinoid X receptor heterodimeric partner.
Whitfield GK; Selznick SH; Haussler CA; Hsieh JC; Galligan MA; Jurutka PW; Thompson PD; Lee SM; Zerwekh JE; Haussler MR
Mol Endocrinol; 1996 Dec; 10(12):1617-31. PubMed ID: 8961271
[TBL] [Abstract][Full Text] [Related]
25. Transcriptional activity of a fluorinated vitamin D analog on VDR-RXR-mediated gene expression.
Sasaki H; Harada H; Handa Y; Morino H; Suzawa M; Shimpo E; Katsumata T; Masuhiro Y; Matsuda K; Ebihara K
Biochemistry; 1995 Jan; 34(1):370-7. PubMed ID: 7819220
[TBL] [Abstract][Full Text] [Related]
26. Singly dehydroxylated A-ring analogues of 19-nor-1alpha,25-dihydroxyvitamin D3 and 19-nor-22-oxa-1alpha,25-dihydroxyvitamin D3: novel vitamin D3 analogues with potent transcriptional activity but extremely low affinity for vitamin D receptor.
Okano T; Nakagawa K; Tsugawa N; Ozono K; Kubodera N; Osawa A; Terada M; Mikami K
Biol Pharm Bull; 1998 Dec; 21(12):1300-5. PubMed ID: 9881643
[TBL] [Abstract][Full Text] [Related]
27. Tumor necrosis factor activates a nuclear inhibitor of vitamin D and retinoid-X receptors.
Fernandez-Martin JL; Kurian S; Farmer P; Nanes MS
Mol Cell Endocrinol; 1998 Jun; 141(1-2):65-72. PubMed ID: 9723887
[TBL] [Abstract][Full Text] [Related]
28. Synthetic LXXLL peptide antagonize 1,25-dihydroxyvitamin D3-dependent transcription.
Pike JW; Pathrose P; Barmina O; Chang CY; McDonnell DP; Yamamoto H; Shevde NK
J Cell Biochem; 2003 Feb; 88(2):252-8. PubMed ID: 12520523
[TBL] [Abstract][Full Text] [Related]
29. Transcriptional repression of the interleukin-2 gene by vitamin D3: direct inhibition of NFATp/AP-1 complex formation by a nuclear hormone receptor.
Alroy I; Towers TL; Freedman LP
Mol Cell Biol; 1995 Oct; 15(10):5789-99. PubMed ID: 7565732
[TBL] [Abstract][Full Text] [Related]
30. New understanding of the molecular mechanism of receptor-mediated genomic actions of the vitamin D hormone.
Haussler MR; Jurutka PW; Hsieh JC; Thompson PD; Selznick SH; Haussler CA; Whitfield GK
Bone; 1995 Aug; 17(2 Suppl):33S-38S. PubMed ID: 8579895
[TBL] [Abstract][Full Text] [Related]
31. Genomic actions of 1,25-dihydroxyvitamin D3.
Whitfield GK; Hsieh JC; Jurutka PW; Selznick SH; Haussler CA; MacDonald PN; Haussler MR
J Nutr; 1995 Jun; 125(6 Suppl):1690S-1694S. PubMed ID: 7782928
[TBL] [Abstract][Full Text] [Related]
32. Vitamin D3- and retinoic acid-induced monocytic differentiation: interactions between the endogenous vitamin D3 receptor, retinoic acid receptors, and retinoid X receptors in U-937 cells.
Botling J; Oberg F; Törmä H; Tuohimaa P; Bläuer M; Nilsson K
Cell Growth Differ; 1996 Sep; 7(9):1239-49. PubMed ID: 8877104
[TBL] [Abstract][Full Text] [Related]
33. 1 alpha,25-Dihydroxy-20-epi-vitamin D3: an extraordinarily potent inhibitor of leukemic cell growth in vitro.
Elstner E; Lee YY; Hashiya M; Pakkala S; Binderup L; Norman AW; Okamura WH; Koeffler HP
Blood; 1994 Sep; 84(6):1960-7. PubMed ID: 8080998
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of the 1,25-dihydroxyvitamin D3-induced increase in vitamin D receptor (VDR) levels and binding of VDR-retinoid X receptor (RXR) to a direct repeat (DR)-3 type response element by an RXR-specific ligand in human keratinocyte cultures.
Jensen TJ; Henriksen LO; Sølvsten H; Kragballe K
Biochem Pharmacol; 1998 Mar; 55(6):767-73. PubMed ID: 9586948
[TBL] [Abstract][Full Text] [Related]
35. The 1,25-dihydroxyvitamin D3 (VD) analogues MC903, EB1089 and KH1060 activate the VD receptor: homodimers show higher ligand sensitivity than heterodimers with retinoid X receptors.
Carlberg C; Mathiasen IS; Saurat JH; Binderup L
J Steroid Biochem Mol Biol; 1994 Nov; 51(3-4):137-42. PubMed ID: 7981122
[TBL] [Abstract][Full Text] [Related]
36. The acute promyelocytic leukemia-associated protein, promyelocytic leukemia zinc finger, regulates 1,25-dihydroxyvitamin D(3)-induced monocytic differentiation of U937 cells through a physical interaction with vitamin D(3) receptor.
Ward JO; McConnell MJ; Carlile GW; Pandolfi PP; Licht JD; Freedman LP
Blood; 2001 Dec; 98(12):3290-300. PubMed ID: 11719366
[TBL] [Abstract][Full Text] [Related]
37. Structural variants of the vitamin D analogue EB1089 reduce its ligand sensitivity and promoter selectivity.
Quack M; Clarin A; Binderup E; Björkling F; Hansen CM; Carlberg C
J Cell Biochem; 1998 Dec; 71(3):340-50. PubMed ID: 9831071
[TBL] [Abstract][Full Text] [Related]
38. High-affinity nuclear receptor binding of 20-epi analogues of 1,25-dihydroxyvitamin D3 correlates well with gene activation.
Nayeri S; Mathiasen IS; Binderup L; Carlberg C
J Cell Biochem; 1996 Sep; 62(3):325-33. PubMed ID: 8872604
[TBL] [Abstract][Full Text] [Related]
39. Superagonistic action of 14-epi-analogs of 1,25-dihydroxyvitamin D explained by vitamin D receptor-coactivator interaction.
Eelen G; Verlinden L; Rochel N; Claessens F; De Clercq P; Vandewalle M; Tocchini-Valentini G; Moras D; Bouillon R; Verstuyf A
Mol Pharmacol; 2005 May; 67(5):1566-73. PubMed ID: 15728261
[TBL] [Abstract][Full Text] [Related]
40. Vitamin D3-retinoid X receptor dimerization, DNA binding, and transactivation are differentially affected by analogs of 1,25-dihydroxyvitamin D3.
Cheskis B; Lemon BD; Uskokovic M; Lomedico PT; Freedman LP
Mol Endocrinol; 1995 Dec; 9(12):1814-24. PubMed ID: 8614417
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
